Ensem’s partner BeiGene doses first five patients in first-in-human phase 1 tria
14 Jun 2024 //
PHARMABIZ
Ensem Therapeutics Announces CDK2 Inhibitor Enters Clinical Trials
12 Jun 2024 //
BUSINESSWIRE
BeiGene to buy global rights to Ensem`s experimental cancer therapy
22 Nov 2023 //
REUTERS
ENSEM Announces the Promotion of Shengfang Jin, PhD to President & CEO
05 Jun 2023 //
PR NEWSWIRE